0 of 7 questions completed
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading...
You must sign in or sign up to start the quiz.
You have to finish following quiz, to start this quiz:
Currently, how confident are you in your ability to:
1 = not confident, 2 = somewhat confident, 3 = confident, 4 = very confident, 5 = extremely confident, N/A = not applicable to me
Consider recently released combination therapy data when making therapeutic decisions for your patients
Provide optimal patient education regarding techniques for preventing/slowing the progression of AD
Indicate how often you CURRENTLY use each of the following clinical practice strategies for your patients with Alzheimer’s disease.
*1 = Never, 2 = Not often, 3 = Sometimes, 4 = Often, 5 = Always, N/A = Not applicable to me
Continually assess, risk-stratify and monitor Alzheimer’s disease patients
Apply recent trial data, including that of emerging agents, in clinical practice
Utilize the interprofessional approach when treating and managing patients with AD
1. All of the following modifiable risk factors reduce the likelihood of Alzheimer’s disease, except:
2. The results of the BAN 2401 Study, a randomized, phase II, double-blind, placebo-controlled analysis of 856 patients with mild cognitive impairment (MCI), revealed that patients receiving the highest treatment dose of 10 mg/kg biweekly experienced:
3. Which of the below best describes the study population for the recent randomized, double-blind, placebo-controlled cross-over trial examining the effect of nabilone on agitation?
4. In the Systolic Blood Pressure Intervention Trial (SPRINT), as an intensive blood pressure (BP) reduction strategy, investigators defied the standard and targeted a systolic BP of:
5. Which of the following is not true regarding Alzheimer’s disease?